Structure

Physi-Chem Properties

Molecular Weight:  532.34
Volume:  555.572
LogP:  2.027
LogD:  1.924
LogS:  -4.417
# Rotatable Bonds:  8
TPSA:  124.29
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.284
Synthetic Accessibility Score:  6.138
Fsp3:  0.871
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.838
MDCK Permeability:  8.34649290482048e-06
Pgp-inhibitor:  0.008
Pgp-substrate:  0.988
Human Intestinal Absorption (HIA):  0.025
20% Bioavailability (F20%):  0.108
30% Bioavailability (F30%):  0.644

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.501
Plasma Protein Binding (PPB):  77.16633605957031%
Volume Distribution (VD):  0.35
Pgp-substrate:  14.192466735839844%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.753
CYP2C19-inhibitor:  0.005
CYP2C19-substrate:  0.764
CYP2C9-inhibitor:  0.013
CYP2C9-substrate:  0.18
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.154
CYP3A4-inhibitor:  0.505
CYP3A4-substrate:  0.124

ADMET: Excretion

Clearance (CL):  3.37
Half-life (T1/2):  0.515

ADMET: Toxicity

hERG Blockers:  0.087
Human Hepatotoxicity (H-HT):  0.638
Drug-inuced Liver Injury (DILI):  0.019
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.92
Maximum Recommended Daily Dose:  0.95
Skin Sensitization:  0.823
Carcinogencity:  0.757
Eye Corrosion:  0.004
Eye Irritation:  0.013
Respiratory Toxicity:  0.97

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC180733

Natural Product ID:  NPC180733
Common Name*:   KALMVCDXDQYBPA-WQXOJWCKSA-N
IUPAC Name:   n.a.
Synonyms:   24-Epiquadrangularic Acid G
Standard InCHIKey:  KALMVCDXDQYBPA-WQXOJWCKSA-N
Standard InCHI:  InChI=1S/C31H48O7/c1-17(2)20(32)8-7-18(25(35)36)19-11-12-28(4)21-9-10-22-29(5,26(37)38-6)23(33)15-24(34)31(22)16-30(21,31)14-13-27(19,28)3/h18-24,32-34H,1,7-16H2,2-6H3,(H,35,36)/t18-,19-,20-,21+,22+,23+,24+,27-,28+,29+,30+,31-/m1/s1
SMILES:  COC(=O)[C@]1(C)[C@@H](O)C[C@@H]([C@]23[C@H]1CC[C@@H]1[C@@]3(C2)CC[C@]2([C@@]1(C)CC[C@@H]2[C@H](C(=O)O)CC[C@H](C(=C)C)O)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL453000
PubChem CID:   10697557
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0002321] Cycloartanols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[10650080]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota seeds n.a. n.a. PMID[10785422]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota Seeds n.a. n.a. PMID[11277757]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota n.a. leaf n.a. PMID[21265555]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota leaves Khon Kaen, Thailand 2006-AUG PMID[21265555]
NPO30384 Combretum quadrangulare Species Combretaceae Eukaryota n.a. n.a. n.a. PMID[9934464]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 > 100.0 ug ml-1 PMID[501079]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC180733 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC37047
1.0 High Similarity NPC41971
0.9681 High Similarity NPC75941
0.9574 High Similarity NPC94906
0.9565 High Similarity NPC288906
0.9565 High Similarity NPC263135
0.9468 High Similarity NPC472028
0.9375 High Similarity NPC124544
0.9255 High Similarity NPC234564
0.9072 High Similarity NPC71706
0.901 High Similarity NPC257082
0.899 High Similarity NPC201763
0.898 High Similarity NPC271980
0.898 High Similarity NPC193934
0.8958 High Similarity NPC469810
0.8947 High Similarity NPC266431
0.8913 High Similarity NPC146937
0.8911 High Similarity NPC163216
0.89 High Similarity NPC37600
0.8889 High Similarity NPC312900
0.8878 High Similarity NPC253886
0.8878 High Similarity NPC121218
0.8878 High Similarity NPC46848
0.8854 High Similarity NPC329910
0.8842 High Similarity NPC470385
0.8842 High Similarity NPC470386
0.8835 High Similarity NPC270586
0.8824 High Similarity NPC285298
0.8812 High Similarity NPC263729
0.8788 High Similarity NPC88203
0.8788 High Similarity NPC246736
0.8788 High Similarity NPC214946
0.8788 High Similarity NPC275990
0.8788 High Similarity NPC148628
0.8788 High Similarity NPC286519
0.8788 High Similarity NPC304832
0.8788 High Similarity NPC76866
0.8763 High Similarity NPC253586
0.875 High Similarity NPC470232
0.875 High Similarity NPC470229
0.8713 High Similarity NPC295366
0.87 High Similarity NPC469985
0.8696 High Similarity NPC302111
0.8687 High Similarity NPC289148
0.8687 High Similarity NPC52899
0.8687 High Similarity NPC163963
0.8687 High Similarity NPC295276
0.8673 High Similarity NPC162459
0.8673 High Similarity NPC28864
0.8673 High Similarity NPC38296
0.8673 High Similarity NPC38471
0.8673 High Similarity NPC474793
0.8673 High Similarity NPC471038
0.8673 High Similarity NPC20479
0.8673 High Similarity NPC98837
0.866 High Similarity NPC470387
0.8646 High Similarity NPC475118
0.8646 High Similarity NPC469982
0.8646 High Similarity NPC47853
0.8632 High Similarity NPC198242
0.8632 High Similarity NPC211403
0.8617 High Similarity NPC213832
0.8617 High Similarity NPC57954
0.8614 High Similarity NPC47281
0.86 High Similarity NPC170615
0.8586 High Similarity NPC108371
0.8586 High Similarity NPC293866
0.8586 High Similarity NPC287676
0.8571 High Similarity NPC190080
0.8571 High Similarity NPC111187
0.8542 High Similarity NPC287118
0.8542 High Similarity NPC244356
0.8542 High Similarity NPC224060
0.8542 High Similarity NPC471902
0.8542 High Similarity NPC473690
0.8529 High Similarity NPC50535
0.8529 High Similarity NPC200957
0.8529 High Similarity NPC138908
0.8515 High Similarity NPC470310
0.8515 High Similarity NPC87927
0.8511 High Similarity NPC471900
0.8511 High Similarity NPC16377
0.85 High Similarity NPC39683
0.85 High Similarity NPC471790
0.85 High Similarity NPC236585
0.8495 Intermediate Similarity NPC70661
0.8485 Intermediate Similarity NPC16911
0.8485 Intermediate Similarity NPC89099
0.8485 Intermediate Similarity NPC78427
0.8485 Intermediate Similarity NPC119036
0.8469 Intermediate Similarity NPC327788
0.8469 Intermediate Similarity NPC200054
0.8469 Intermediate Similarity NPC29410
0.8447 Intermediate Similarity NPC201908
0.8447 Intermediate Similarity NPC176949
0.8447 Intermediate Similarity NPC166993
0.8438 Intermediate Similarity NPC471901
0.8438 Intermediate Similarity NPC475416
0.8438 Intermediate Similarity NPC470230
0.8431 Intermediate Similarity NPC98603
0.8431 Intermediate Similarity NPC84928
0.8421 Intermediate Similarity NPC24705
0.8421 Intermediate Similarity NPC56962
0.8404 Intermediate Similarity NPC269360
0.8404 Intermediate Similarity NPC134197
0.8404 Intermediate Similarity NPC33768
0.8404 Intermediate Similarity NPC264005
0.84 Intermediate Similarity NPC470388
0.8396 Intermediate Similarity NPC476964
0.8384 Intermediate Similarity NPC170978
0.8384 Intermediate Similarity NPC10864
0.8367 Intermediate Similarity NPC98639
0.8367 Intermediate Similarity NPC205173
0.8365 Intermediate Similarity NPC218123
0.8365 Intermediate Similarity NPC211224
0.8365 Intermediate Similarity NPC112895
0.8365 Intermediate Similarity NPC273155
0.8365 Intermediate Similarity NPC231278
0.8351 Intermediate Similarity NPC477855
0.8351 Intermediate Similarity NPC294263
0.835 Intermediate Similarity NPC265127
0.835 Intermediate Similarity NPC28791
0.835 Intermediate Similarity NPC285927
0.8333 Intermediate Similarity NPC194485
0.8333 Intermediate Similarity NPC53890
0.8333 Intermediate Similarity NPC209298
0.8333 Intermediate Similarity NPC219937
0.8333 Intermediate Similarity NPC123252
0.8333 Intermediate Similarity NPC169933
0.8333 Intermediate Similarity NPC139347
0.8333 Intermediate Similarity NPC122811
0.8333 Intermediate Similarity NPC277074
0.8333 Intermediate Similarity NPC216114
0.8333 Intermediate Similarity NPC10274
0.8302 Intermediate Similarity NPC470281
0.8302 Intermediate Similarity NPC470311
0.8302 Intermediate Similarity NPC94650
0.8298 Intermediate Similarity NPC12774
0.8298 Intermediate Similarity NPC2783
0.8283 Intermediate Similarity NPC13949
0.828 Intermediate Similarity NPC299963
0.8269 Intermediate Similarity NPC251824
0.8269 Intermediate Similarity NPC471246
0.8269 Intermediate Similarity NPC86852
0.8265 Intermediate Similarity NPC215271
0.8265 Intermediate Similarity NPC153775
0.8265 Intermediate Similarity NPC29247
0.8265 Intermediate Similarity NPC289539
0.8265 Intermediate Similarity NPC261333
0.8265 Intermediate Similarity NPC111524
0.8265 Intermediate Similarity NPC104371
0.8265 Intermediate Similarity NPC91772
0.8265 Intermediate Similarity NPC101233
0.8265 Intermediate Similarity NPC292374
0.8265 Intermediate Similarity NPC129004
0.8265 Intermediate Similarity NPC277399
0.8252 Intermediate Similarity NPC301787
0.8247 Intermediate Similarity NPC198054
0.8247 Intermediate Similarity NPC250753
0.8229 Intermediate Similarity NPC471043
0.8218 Intermediate Similarity NPC477521
0.8211 Intermediate Similarity NPC4643
0.8211 Intermediate Similarity NPC259009
0.8211 Intermediate Similarity NPC57469
0.8208 Intermediate Similarity NPC255655
0.8208 Intermediate Similarity NPC130302
0.8191 Intermediate Similarity NPC264317
0.8191 Intermediate Similarity NPC294438
0.8182 Intermediate Similarity NPC279974
0.8182 Intermediate Similarity NPC210214
0.8173 Intermediate Similarity NPC222833
0.8173 Intermediate Similarity NPC4115
0.8172 Intermediate Similarity NPC471037
0.8165 Intermediate Similarity NPC469794
0.8165 Intermediate Similarity NPC72772
0.8163 Intermediate Similarity NPC199543
0.8163 Intermediate Similarity NPC26046
0.8163 Intermediate Similarity NPC181594
0.8163 Intermediate Similarity NPC291373
0.8163 Intermediate Similarity NPC144739
0.8155 Intermediate Similarity NPC96217
0.8155 Intermediate Similarity NPC222153
0.8144 Intermediate Similarity NPC46758
0.8144 Intermediate Similarity NPC80401
0.8144 Intermediate Similarity NPC100313
0.8137 Intermediate Similarity NPC148279
0.8137 Intermediate Similarity NPC289670
0.8137 Intermediate Similarity NPC252614
0.8125 Intermediate Similarity NPC160304
0.8125 Intermediate Similarity NPC474719
0.8125 Intermediate Similarity NPC183374
0.8125 Intermediate Similarity NPC4309
0.8125 Intermediate Similarity NPC211162
0.8113 Intermediate Similarity NPC154906
0.8113 Intermediate Similarity NPC471250
0.8105 Intermediate Similarity NPC475007
0.81 Intermediate Similarity NPC195366
0.81 Intermediate Similarity NPC114743
0.81 Intermediate Similarity NPC135548
0.81 Intermediate Similarity NPC264979

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC180733 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8191 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD8035 Phase 2
0.7879 Intermediate Similarity NPD8034 Phase 2
0.7864 Intermediate Similarity NPD7639 Approved
0.7864 Intermediate Similarity NPD7640 Approved
0.7826 Intermediate Similarity NPD6114 Approved
0.7826 Intermediate Similarity NPD6697 Approved
0.7826 Intermediate Similarity NPD6118 Approved
0.7826 Intermediate Similarity NPD6115 Approved
0.7767 Intermediate Similarity NPD7638 Approved
0.7609 Intermediate Similarity NPD6117 Approved
0.7527 Intermediate Similarity NPD6116 Phase 1
0.7523 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5739 Approved
0.75 Intermediate Similarity NPD7128 Approved
0.75 Intermediate Similarity NPD6675 Approved
0.75 Intermediate Similarity NPD6402 Approved
0.75 Intermediate Similarity NPD5328 Approved
0.7391 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD7632 Discontinued
0.7364 Intermediate Similarity NPD7320 Approved
0.7364 Intermediate Similarity NPD6899 Approved
0.7364 Intermediate Similarity NPD6881 Approved
0.7355 Intermediate Similarity NPD7319 Approved
0.7353 Intermediate Similarity NPD7637 Suspended
0.7353 Intermediate Similarity NPD6079 Approved
0.7312 Intermediate Similarity NPD3703 Phase 2
0.7304 Intermediate Similarity NPD7115 Discovery
0.7297 Intermediate Similarity NPD6372 Approved
0.7297 Intermediate Similarity NPD6373 Approved
0.7282 Intermediate Similarity NPD6399 Phase 3
0.7273 Intermediate Similarity NPD5701 Approved
0.7273 Intermediate Similarity NPD5697 Approved
0.7265 Intermediate Similarity NPD6319 Approved
0.7232 Intermediate Similarity NPD7102 Approved
0.7232 Intermediate Similarity NPD6883 Approved
0.7232 Intermediate Similarity NPD7290 Approved
0.7222 Intermediate Similarity NPD5211 Phase 2
0.7193 Intermediate Similarity NPD4632 Approved
0.7193 Intermediate Similarity NPD8133 Approved
0.7184 Intermediate Similarity NPD7515 Phase 2
0.7182 Intermediate Similarity NPD6008 Approved
0.7172 Intermediate Similarity NPD4786 Approved
0.717 Intermediate Similarity NPD4755 Approved
0.7168 Intermediate Similarity NPD6847 Approved
0.7168 Intermediate Similarity NPD6649 Approved
0.7168 Intermediate Similarity NPD6650 Approved
0.7168 Intermediate Similarity NPD6617 Approved
0.7168 Intermediate Similarity NPD8130 Phase 1
0.7168 Intermediate Similarity NPD6869 Approved
0.7167 Intermediate Similarity NPD7492 Approved
0.7143 Intermediate Similarity NPD6014 Approved
0.7143 Intermediate Similarity NPD6013 Approved
0.7143 Intermediate Similarity NPD6012 Approved
0.7131 Intermediate Similarity NPD7736 Approved
0.7119 Intermediate Similarity NPD6059 Approved
0.7119 Intermediate Similarity NPD6054 Approved
0.7115 Intermediate Similarity NPD5779 Approved
0.7115 Intermediate Similarity NPD5778 Approved
0.7107 Intermediate Similarity NPD6616 Approved
0.7107 Intermediate Similarity NPD7507 Approved
0.7105 Intermediate Similarity NPD8297 Approved
0.7105 Intermediate Similarity NPD6882 Approved
0.7091 Intermediate Similarity NPD5141 Approved
0.7083 Intermediate Similarity NPD7604 Phase 2
0.708 Intermediate Similarity NPD4634 Approved
0.7075 Intermediate Similarity NPD5221 Approved
0.7075 Intermediate Similarity NPD4697 Phase 3
0.7075 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD5222 Approved
0.7071 Intermediate Similarity NPD4788 Approved
0.7054 Intermediate Similarity NPD6011 Approved
0.7049 Intermediate Similarity NPD8293 Discontinued
0.7049 Intermediate Similarity NPD7078 Approved
0.7048 Intermediate Similarity NPD7748 Approved
0.7037 Intermediate Similarity NPD4696 Approved
0.7037 Intermediate Similarity NPD5285 Approved
0.7037 Intermediate Similarity NPD4700 Approved
0.7037 Intermediate Similarity NPD5286 Approved
0.703 Intermediate Similarity NPD3618 Phase 1
0.7019 Intermediate Similarity NPD6411 Approved
0.7018 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD6009 Approved
0.7009 Intermediate Similarity NPD6084 Phase 2
0.7009 Intermediate Similarity NPD6083 Phase 2
0.7009 Intermediate Similarity NPD5173 Approved
0.7 Intermediate Similarity NPD6370 Approved
0.6991 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6989 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6989 Remote Similarity NPD4808 Clinical (unspecified phase)
0.697 Remote Similarity NPD3667 Approved
0.6939 Remote Similarity NPD7525 Registered
0.6917 Remote Similarity NPD6016 Approved
0.6917 Remote Similarity NPD6015 Approved
0.6909 Remote Similarity NPD5225 Approved
0.6909 Remote Similarity NPD4633 Approved
0.6909 Remote Similarity NPD5224 Approved
0.6909 Remote Similarity NPD5226 Approved
0.6864 Remote Similarity NPD8295 Clinical (unspecified phase)
0.686 Remote Similarity NPD5988 Approved
0.6852 Remote Similarity NPD7902 Approved
0.6847 Remote Similarity NPD5174 Approved
0.6847 Remote Similarity NPD5175 Approved
0.6827 Remote Similarity NPD6101 Approved
0.6827 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6822 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6818 Remote Similarity NPD5223 Approved
0.6803 Remote Similarity NPD8328 Phase 3
0.6792 Remote Similarity NPD4202 Approved
0.6789 Remote Similarity NPD4225 Approved
0.6783 Remote Similarity NPD5955 Clinical (unspecified phase)
0.678 Remote Similarity NPD6868 Approved
0.678 Remote Similarity NPD6274 Approved
0.6777 Remote Similarity NPD5983 Phase 2
0.6777 Remote Similarity NPD6921 Approved
0.6774 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6774 Remote Similarity NPD3699 Clinical (unspecified phase)
0.675 Remote Similarity NPD7101 Approved
0.675 Remote Similarity NPD7100 Approved
0.6733 Remote Similarity NPD6695 Phase 3
0.6731 Remote Similarity NPD5737 Approved
0.6731 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6731 Remote Similarity NPD6672 Approved
0.6726 Remote Similarity NPD4767 Approved
0.6726 Remote Similarity NPD4768 Approved
0.6699 Remote Similarity NPD7334 Approved
0.6699 Remote Similarity NPD7521 Approved
0.6699 Remote Similarity NPD6684 Approved
0.6699 Remote Similarity NPD6409 Approved
0.6699 Remote Similarity NPD7146 Approved
0.6699 Remote Similarity NPD5330 Approved
0.6696 Remote Similarity NPD4754 Approved
0.6694 Remote Similarity NPD6336 Discontinued
0.6667 Remote Similarity NPD4753 Phase 2
0.6667 Remote Similarity NPD3133 Approved
0.6667 Remote Similarity NPD7327 Approved
0.6667 Remote Similarity NPD6053 Discontinued
0.6667 Remote Similarity NPD6335 Approved
0.6667 Remote Similarity NPD5695 Phase 3
0.6667 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3666 Approved
0.6667 Remote Similarity NPD6412 Phase 2
0.6667 Remote Similarity NPD1700 Approved
0.6667 Remote Similarity NPD3665 Phase 1
0.6667 Remote Similarity NPD7328 Approved
0.6667 Remote Similarity NPD6929 Approved
0.6639 Remote Similarity NPD6908 Approved
0.6639 Remote Similarity NPD6909 Approved
0.6636 Remote Similarity NPD5696 Approved
0.6632 Remote Similarity NPD6081 Approved
0.6612 Remote Similarity NPD7516 Approved
0.6609 Remote Similarity NPD4730 Approved
0.6609 Remote Similarity NPD4729 Approved
0.6609 Remote Similarity NPD6686 Approved
0.6609 Remote Similarity NPD5128 Approved
0.66 Remote Similarity NPD6931 Approved
0.66 Remote Similarity NPD6930 Phase 2
0.6598 Remote Similarity NPD3702 Approved
0.6587 Remote Similarity NPD6033 Approved
0.6583 Remote Similarity NPD6317 Approved
0.6574 Remote Similarity NPD7900 Approved
0.6574 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6571 Remote Similarity NPD6903 Approved
0.6566 Remote Similarity NPD5784 Clinical (unspecified phase)
0.6552 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6538 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6538 Remote Similarity NPD5786 Approved
0.6535 Remote Similarity NPD6902 Approved
0.6529 Remote Similarity NPD6314 Approved
0.6529 Remote Similarity NPD6313 Approved
0.6526 Remote Similarity NPD4789 Approved
0.6526 Remote Similarity NPD4245 Approved
0.6526 Remote Similarity NPD4244 Approved
0.6522 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6505 Remote Similarity NPD3668 Phase 3
0.6504 Remote Similarity NPD8296 Approved
0.6504 Remote Similarity NPD8378 Approved
0.6504 Remote Similarity NPD8380 Approved
0.6504 Remote Similarity NPD8335 Approved
0.6504 Remote Similarity NPD8379 Approved
0.65 Remote Similarity NPD7645 Phase 2
0.6496 Remote Similarity NPD5249 Phase 3
0.6496 Remote Similarity NPD5247 Approved
0.6496 Remote Similarity NPD5248 Approved
0.6496 Remote Similarity NPD5251 Approved
0.6496 Remote Similarity NPD5250 Approved
0.6491 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6489 Remote Similarity NPD5360 Phase 3
0.6489 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6476 Remote Similarity NPD7750 Discontinued
0.6476 Remote Similarity NPD7524 Approved
0.6466 Remote Similarity NPD5168 Approved
0.6465 Remote Similarity NPD5776 Phase 2
0.6465 Remote Similarity NPD6925 Approved
0.6458 Remote Similarity NPD5777 Approved
0.6452 Remote Similarity NPD4224 Phase 2
0.6441 Remote Similarity NPD5216 Approved
0.6441 Remote Similarity NPD5217 Approved
0.6441 Remote Similarity NPD5215 Approved
0.6429 Remote Similarity NPD6942 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data